Global Science: A Must-Have Stock Selection by Foreign Investment Expert David Barrosse

Global Science: A Must-Have Stock Selection by Foreign Investment Expert David Barrosse

Have a question?

We want to hear from you. Let us know your question and a research analyst will get back to you promptly. We love to discuss our research.

Connect

Our Latest Insights

Untangling the Outlook for NIH Funding and Its Impact on Pharma

Untangling the Outlook for NIH Funding and Its Impact on Pharma

Capstone believes funding for the National Institutes of Health (NIH) will remain stable for the next 3-5 years, and investors should look past headline appropriations to specific therapeutic area (TA) to assess regulatory risk. Congress continues to insulate funding...

The IRS Ruling Targeting Tax-Aware ETF Strategies

The IRS Ruling Targeting Tax-Aware ETF Strategies

We believe the Internal Revenue Service’s (IRS) September 28th ruling taxing certain Section 351 transactions signals further restrictions on other aggressive tax-aware strategies over the next two years, which is a negative for exchange-traded fund (ETF) sponsors and...